Literature DB >> 18667915

Celiac disease.

Isabel Polanco1.   

Abstract

Celiac disease is an immunologically mediated enteropathy of the small intestine, characterized by lifelong intolerance to the gliadin and related prolamines from wheat and other cereals, that occurs in genetically predisposed individuals. Symptoms result from structural damage to the mucosa of the small intestine, which may cause malabsorption with positive autoantibodies in the sera. Normal mucosal architecture is restored after the use of a gluten-free diet and the normalization of the autoantibodies. Villous atrophy and high levels of autoantibodies reappear when gluten is reintroduced into the diet (gluten challenge).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18667915     DOI: 10.1097/MPG.0b013e3181818df5

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  5 in total

1.  Regulated traffic of anion transporters in mammalian Brunner's glands: a role for water and fluid transport.

Authors:  Anne M Collaco; Robert L Jakab; Nadia E Hoekstra; Kisha A Mitchell; Amos Brooks; Nadia A Ameen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-06-06       Impact factor: 4.052

2.  [Prevalence of an association between coeliac disease and vitiligo].

Authors:  J Henker; A Hartmann
Journal:  Hautarzt       Date:  2019-12       Impact factor: 0.751

Review 3.  Screening of celiac disease in Down syndrome - Old and new dilemmas.

Authors:  Momcilo Pavlovic; Karolina Berenji; Marko Bukurov
Journal:  World J Clin Cases       Date:  2017-07-16       Impact factor: 1.337

Review 4.  Association between celiac disease and vitiligo: A review of the literature.

Authors:  Jing-Zhan Zhang; Dilinuer Abudoureyimu; Man Wang; Shi-Rong Yu; Xiao-Jing Kang
Journal:  World J Clin Cases       Date:  2021-12-06       Impact factor: 1.337

5.  Gastrointestinal microbiota and some children diseases: a review.

Authors:  Thabata Koester Weber; Isabel Polanco
Journal:  Gastroenterol Res Pract       Date:  2012-10-30       Impact factor: 2.260

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.